Phase II randomised trial of type I interferon inhibitor anifrolumab in patients with active lupus nephritis.

David JayneBrad RovinEduardo F MyslerRichard A Furie Frederic A HoussiauTeodora TrasievaJacob KnagenhjelmErik SchwetjeYen Lin ChiaRaj TummalaCatharina Lindholm

Published in: Annals of the rheumatic diseases (2022)

NCT02547922.

Keyphrases

phase ii
open label
clinical trial
phase iii
study protocol
dendritic cells
placebo controlled
double blind
randomized controlled trial
immune response